To evaluate the association between biological Disease-Modifying Anti-Rheumatic Drugs (bDMARDs) use and quality of life (QoL) in patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and
This perspective cohort study aimed to assess changes in quality of life (QoL) between orthodontic-first approach (OFA) and surgery-first approach (SFA) patients. Sixty patients who underwent orthogna
Sickle cell disease (SCD) is a lifelong blood disorder affecting approximately 100,000 individuals in the United States (US). A number of new treatments have recently become available to improve SCD c